Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Laforêt

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Neurology|April 3, 2015
Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type IIINicolai Preisler, Pascal Laforêt, Karen Lindhardt Madsen, et al.
Neuromuscular Disorders : NMD|April 9, 2008
Left ventricular non-compaction in a patient with myotonic dystrophy type 2Karim Wahbi, Christophe Meune, Guillaume Bassez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 9, 2013
POLG mutations associated with remitting/relapsing neurological eventsBertrand Degos, Pascal Laforêt, Claude Jardel, et al.
Neuromuscular Disorders : NMD|May 22, 2014
Atrio-ventricular block requiring pacemaker in patients with late onset Pompe diseaseSabrina Sacconi, Karim Wahbi, Guillaume Theodore, et al.
Neuromuscular Disorders : NMD|October 29, 2021
Whole-body muscle MRI in McArdle diseaseDavid Tobaly, Pascal Laforêt, Tanya Stojkovic, et al.
Neuromuscular Disorders : NMD|April 25, 2008
Severe neonatal myasthenia due to maternal anti-MuSK antibodiesAnthony Béhin, Michèle Mayer, Bouchera Kassis-Makhoul, et al.
Neuromuscular Disorders : NMD|June 2, 2009
Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control studyKarim Wahbi, Christophe Meune, Henri Marc Bécane, et al.
Clinical Therapeutics|October 8, 2009
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trialDavid Orlikowski, Sylvie Chevret, Maria Antonia Quera-Salva, et al.
Endocrine Connections|May 12, 2017
Skeletal muscle metabolism during prolonged exercise in Pompe diseaseNicolai Preisler, Pascal Laforêt, Karen Lindhardt Madsen, et al.
European Journal of Neurology|November 20, 2022
Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapyDiana Maria Chitimus, Edouard Berling, Laurent Garderet, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Neurology|April 3, 2015
Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type IIINicolai Preisler, Pascal Laforêt, Karen Lindhardt Madsen, et al.
Neuromuscular Disorders : NMD|April 9, 2008
Left ventricular non-compaction in a patient with myotonic dystrophy type 2Karim Wahbi, Christophe Meune, Guillaume Bassez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 9, 2013
POLG mutations associated with remitting/relapsing neurological eventsBertrand Degos, Pascal Laforêt, Claude Jardel, et al.
Neuromuscular Disorders : NMD|May 22, 2014
Atrio-ventricular block requiring pacemaker in patients with late onset Pompe diseaseSabrina Sacconi, Karim Wahbi, Guillaume Theodore, et al.
Neuromuscular Disorders : NMD|October 29, 2021
Whole-body muscle MRI in McArdle diseaseDavid Tobaly, Pascal Laforêt, Tanya Stojkovic, et al.
Neuromuscular Disorders : NMD|April 25, 2008
Severe neonatal myasthenia due to maternal anti-MuSK antibodiesAnthony Béhin, Michèle Mayer, Bouchera Kassis-Makhoul, et al.
Neuromuscular Disorders : NMD|June 2, 2009
Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control studyKarim Wahbi, Christophe Meune, Henri Marc Bécane, et al.
Clinical Therapeutics|October 8, 2009
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trialDavid Orlikowski, Sylvie Chevret, Maria Antonia Quera-Salva, et al.
Endocrine Connections|May 12, 2017
Skeletal muscle metabolism during prolonged exercise in Pompe diseaseNicolai Preisler, Pascal Laforêt, Karen Lindhardt Madsen, et al.
European Journal of Neurology|November 20, 2022
Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapyDiana Maria Chitimus, Edouard Berling, Laurent Garderet, et al.
Pageof 17